Restricted accessLetterFirst published online 2026-4
Letter: Comment on;“Left Ventricular Global Function Index and Major Adverse Cardiovascular Events Linked to Systemic Inflammation in Acute Coronary Syndrome”
KivrakATanikVOTuncaCCanpolatU. The association between left ventricular global function index and major adverse cardiovascular events linked to systemic inflammation in acute coronary syndrome. Angiology. 2026;77(4):488-97.
2.
AydınCUyanUKaradenizMDemirkıranA. Role of simple inflammatory parameters in predicting the severity of coronary artery disease. Rev Assoc Med Bras (1992). 2023;9:e20230518.
3.
OkkonenMHavulinnaASUkkolaO, et al. Risk factors for major adverse cardiovascular events after the first acute coronary syndrome. Ann Med. 2021;53:817-23.
4.
ZhangJTangZJiangJ, et al. Clinical and prognostic value of non-fasting lipoproteins and apolipoproteins in Chinese patients with coronary heart disease. Rev Cardiovasc Med. 2023;24:314.
5.
EvansMRobertsADaviesSReesA.Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs. 2004;64:1181-96.
6.
CannonCPBraunwaldEMcCabeCH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2006;354:778.
7.
DemirkıranAAydınCÖrünSKaplangörayM. Can the SYNTAX score predict mortality in patients with cardiac arrest?Rev Assoc Med Bras (1992). 2024;70:e20240647.
